Table 2.
Dose and Period of Melatonin Treatment | Animal Models | Species/Gender | Age at Evaluation | Reprogramming Effects | References |
---|---|---|---|---|---|
Melatonin 10 mg/kg/day s.c. throughout pregnancy | Maternal methionine intake-induced hyperhomocysteinemia | Wistar rat/M and F | 75 days | Prevented cognition deficit | [74] |
0.01% melatonin in drinking water during pregnancy and lactation | Maternal caloric restriction | SD rat/M | 12 wks | Prevented hypertension and increased renal NO | [75] |
0.01% melatonin in drinking water during pregnancy and lactation | Maternal L-NAME exposure | SD rat/M | 12 wks | Prevented hypertension and increased renal NO | [76] |
0.01% melatonin in drinking water during pregnancy and lactation | Maternal high-fructose diet | SD rat/M | 12 wks | Prevented hypertension and increased renal NO | [77] |
Melatonin (40 μg/mL) in drinking water from gestational days 0 to 19 | Maternal phenytoin exposure | Wistar rat/M and F | 12 wks | Protected neurobehavioral dysfunctions | [78] |
0.01% melatonin in drinking water during pregnancy and lactation | Maternal continuous light exposure | SD rat/M | 12 wks | Prevented hypertension | [79] |
Melatonin 1 mg/kg s.c. injection at circadian time 12, from day 17 to 21 of pregnancy | Constant light exposure from gestational day 10 to 21 | Wistar rat/M | 16 wks | Protected anxiety-like and sexual behaviors | [80] |
0.01% melatonin in drinking water during pregnancy and lactation | Maternal high methyl-donor diet | SD rat/M | 12 wks | Attenuated hypertension and altered renal transcriptome | [81] |
0.01% melatonin in drinking water during pregnancy and lactation | Maternal high-fructose diet plus post-weaning high-salt diet | SD rat/M | 12 wks | Attenuated hypertension and restored NO system | [82] |
0.01% melatonin in drinking water during pregnancy and lactation | Prenatal dexamethasone exposure | SD rat/M | 16 wks | Protected hippocampal morphology and reelin level | [83] |
0.01% melatonin in drinking water during pregnancy and lactation | Prenatal dexamethasone exposure | SD rat/M | 16 wks | Prevented hypertension and increased nephron number | [48] |
0.01% melatonin in drinking water during pregnancy and lactation | Neonatal dexamethasone exposure | SD rat/M | 16 wks | Prevented hypertension and preserved histone deacetylase gene expression | [84] |
0.01% melatonin in drinking water during lactation | Neonatal dexamethasone exposure | SD rat/M | 16 wks | Prevented hypertension and increased renal melatonin level and MT2 protein | [85] |
0.01% melatonin in drinking water during pregnancy and lactation | Prenatal dexamethasone exposure plus post-weaning high-fat diet | SD rat/M | 16 wks | Prevented hypertension and up-regulated Agtr1b and Mas1 expression | [86] |
Studies tabulated according to animal models, species, and age at evaluation. Legend: SD, Sprague-Dawley; M, male; F, female; s.c., subcutaneous; L-NAME, NG-nitro-l-arginine methyl ester.